撒哈拉以南非洲血流感染中产超广谱β-内酰胺酶革兰阴性菌的多国分布与特征
克雷伯菌属表型ESBL率最高(45.5%),其次为不动杆菌属(16.2%)、大肠埃希菌(5.7%)和非伤寒沙门菌(1.3%)。结论确认撒哈拉以南非洲血流感染病原体中存在ESBL产生,需紧急采取防控措施。
要点
- 撒哈拉以南非洲血流感染革兰阴性分离株表型ESBL率为12.1%。
- 克雷伯菌属表型ESBL率最高,达45.5%(40/88)。
- 非伤寒沙门菌表型ESBL率较低,为1.3%(2/159)。
核心结论
- 研究确认撒哈拉以南非洲血流感染病原体中存在ESBL产生,需紧急控制抗菌药物耐药的发生与扩散。
研究设计与样本
- 数据来自非洲伤寒监测项目(TSAP),2010–2014年在9个撒哈拉以南非洲国家的12个卫生机构对发热患者行标准化血培养。
- 分离株先在哨点鉴定,后经中心参考实验室确认,并对所有病原体行药敏试验、ESBL表型检测和常规多重PCR检测β-内酰胺酶编码基因。
主要发现
- 88株克雷伯菌属中40株(45.5%)表型ESBL阳性。
- 122株大肠埃希菌中7株(5.7%)表型ESBL阳性。
- 37株不动杆菌属中6株(16.2%)表型ESBL阳性。
- 159株非伤寒沙门菌中2株(1.3%)表型ESBL阳性。
临床怎么用
- 在撒哈拉以南非洲,血流感染经验性治疗需考虑产ESBL革兰阴性菌,尤其克雷伯菌属。
- 当地可选替代药物有限,应加强抗菌药物耐药监测与控制措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antimicrobial resistance (AMR) is a major global health concern, yet, there are noticeable gaps in AMR surveillance data in regions such as sub-Saharan Africa. We aimed to measure the prevalence of extended-spectrum β-lactamase (ESBL) producing Gram-negative bacteria in bloodstream infections from 12 sentinel sites in sub-Saharan Africa. METHODS: Data were generated during the Typhoid Fever Surveillance in Africa Program (TSAP), in which standardized blood cultures were performed on febrile patients attending 12 health facilities in 9 sub-Saharan African countries between 2010 and 2014. Pathogenic bloodstream isolates were identified at the sites and then subsequently confirmed at a central reference laboratory. Antimicrobial susceptibility testing, detection of ESBL production, and conventional multiplex polymerase chain reaction (PCR) testing for genes encoding for β-lactamase were performed on all pathogens. RESULTS: Five hundred and five pathogenic Gram-negative bloodstream isolates were isolated during the study period and available for further characterization. This included 423 Enterobacteriaceae. Phenotypically, 61 (12.1%) isolates exhibited ESBL activity, and genotypically, 47 (9.3%) yielded a PCR amplicon for at least one of the screened ESBL genes. Among specific Gram-negative isolates, 40 (45.5%) of 88 Klebsiella spp., 7 (5.7%) of 122 Escherichia coli, 6 (16.2%) of 37 Acinetobacter spp., and 2 (1.3%) of 159 of nontyphoidal Salmonella (NTS) showed phenotypic ESBL activity. CONCLUSIONS: Our findings confirm the presence of ESBL production among pathogens causing bloodstream infections in sub-Saharan Africa. With few alternatives for managing ESBL-producing pathogens in the African setting, measures to control the development and proliferation of AMR organisms are urgently needed.
引用
- Toy T, Pak GD, Duc TP, et al. Multicountry Distribution and Characterization of Extended-spectrum β-Lactamase-associated Gram-negative Bacteria From Bloodstream Infections in Sub-Saharan Africa. Clin Infect Dis. 2019. PMID: 31665776. doi:10.1093/cid/ciz450
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。